| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.12.24 | Vertex Pharmaceuticals Incorporated: Vertex Presents Positive Long-Term Data On CASGEVY (exagamglogene autotemcel) at the American Society of Hematology (ASH) Annual Meeting and Exposition and Provides Program Update | 648 | Business Wire | - Data from long-term follow-up of patients in clinical trials further demonstrate durability of the transformative benefits of CASGEVY -
Safety profile consistent with busulfan conditioning and... ► Artikel lesen | |
| 08.12.24 | Genmab A/S: Investigational Epcoritamab (DuoBody CD3xCD20) Monotherapy Achieves High Overall and Complete Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) in Preliminary Analysis | 605 | Business Wire | Genmab A/S (Nasdaq: GMAB):
Preliminary analyses from the EPCORECLL-1 trial demonstrates overall response rate (ORR) of 61 percent and complete response (CR) rate of 39 percent in heavily pretreated... ► Artikel lesen | |
| 08.12.24 | Genmab A/S: Investigational Epcoritamab (DuoBody CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) | 847 | Business Wire | Genmab A/S (Nasdaq: GMAB):
Results show 96 percent overall response rate (ORR), 87 percent complete response (CR), and 80 percent 21-month progression-free survival (PFS) in patients with... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 2.513 |
| TESLA | 2.326 |
| THYSSENKRUPP | 2.220 |
| RENK GROUP | 1.990 |
| DEUTZ | 1.769 |
| STEYR MOTORS | 1.754 |
| BYD | 1.678 |
| NEL | 1.670 |
| RHEINMETALL | 1.639 |
| BAYER | 1.489 |
| XIAOMI | 1.377 |
| TUI | 1.367 |
| NOVO NORDISK | 1.185 |
| EVOTEC | 1.082 |
| COMMERZBANK | 901 |
| DEUTSCHE BANK | 790 |
| VOLKSWAGEN | 772 |
| MUTARES | 764 |
| AIXTRON SE | 726 |
| MERCEDES-BENZ | 716 |
| NORDEX | 702 |
| BASF | 660 |
| PORSCHE AG | 655 |
| PUMA | 626 |
| RWE | 617 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
